{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T16:40:03Z","timestamp":1787071203320,"version":"build-2736575974"},"reference-count":12,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","license":[{"start":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T00:00:00Z","timestamp":1738627200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["J West Afr Coll Surg"],"published-print":{"date-parts":[[2025,4]]},"abstract":"Abstract<\/jats:title>\n \n Background:<\/jats:title>\n Chronic liver disease (CLD) in the clinical context is a disease process affecting the liver, which involves a process of progressive destruction and regeneration of the liver parenchyma, leading to fibrosis and cirrhosis. Both FibroScan, which is an ultrasound study also known as transient elastography, and Hyaluran test (biochemical test) are rapid safe non-invasive examinations of the liver, which can be used to monitor the degree and progression of fibrotic changes in the liver.<\/jats:p>\n <\/jats:sec>\n \n Objective:<\/jats:title>\n The purpose of this study was to compare the degree of liver fibrosis, as measured on ultrasound-based FibroScan and Hyaluran tests in CLD.<\/jats:p>\n <\/jats:sec>\n \n Materials and Methods:<\/jats:title>\n This was a two-stage comparative study carried out on patients with clinically diagnosed CLD and non-CLD subjects at Jos University Teaching Hospital (JUTH) from January to June 2022. The first stage involved the use of ultrasound-based FibroScan to assess the degree of tissue stiffness in the liver of both CLD and non-CLD subjects. The unit of measurement of FibroScan is kilopascals (Kpa). In the second stage, blood samples were collected from CLD and non-CLD subjects for Hyaluran tests. The unit of measurement of Hyaluran tests is expressed in nanograms per milliliter (ng\/mL).<\/jats:p>\n <\/jats:sec>\n \n Results:<\/jats:title>\n \n This study comprises of 75 apparently normal subjects and 75 CLD patients. The mean FibroScan level was significantly higher (17.55 \u00b1 7.5 kPa) in patients with CLD compared to apparently normal subjects (5.06 \u00b1 3.1 kPa),\n t<\/jats:italic>\n = 5.783;\n P<\/jats:italic>\n < 0.001. The mean Hyaluran value in the patients with CLD was 30.01 \u00b1 20.39\u2009ng\/mL, which was significantly higher than that in the normal subjects with the mean value of 20.39 \u00b1 8.27\u2009ng\/mL,\n t<\/jats:italic>\n = 3.784;\n P<\/jats:italic>\n < 0.001. In evaluating the correlation between FibroScan and Hyaluran in assessing the degree of fibrosis using the Spearman correlation coefficient, it was observed that the degree of fibrosis at the earlier stage (minimal) signifies a positive but weak correlation (\n P<\/jats:italic>\n = 0.151), but this was not statistically significant (\n P<\/jats:italic>\n = 0.492). However, mild\/moderate and severe fibrosis demonstrate moderate positive (\n P =<\/jats:italic>\n 0.505 and 0.550) and statistically significant correlation with\n P<\/jats:italic>\n value of 0.020 and 0.011, respectively.\n <\/jats:p>\n <\/jats:sec>\n \n Conclusion:<\/jats:title>\n The study demonstrated a statistically significant difference in the mean FibroScan value in non-CLD and CLD cases. The results also indicated statistically significant difference in the mean Hyaluran value in non-CLD and the CLD cases. The study demonstrated a significant correlation between Hyaluran and FibroScan in assessing the degree of moderate and severe fibrosis in CLD.<\/jats:p>\n <\/jats:sec>","DOI":"10.4103\/jwas.jwas_82_23","type":"journal-article","created":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T11:08:32Z","timestamp":1738667312000},"page":"136-141","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Comparative Evaluation of the Degree of Liver Fibrosis on Ultrasound-Based Fibroscan and Hyaluran Tests in Patients with Chronic Liver Disease"],"prefix":"10.4103","volume":"15","author":[{"given":"Benjamin","family":"Egbo","sequence":"first","affiliation":[{"name":"Department of Radiology, Jos University Teaching Hospital, University of Jos, Jos, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Ani","sequence":"additional","affiliation":[{"name":"Department of Radiology, Jos University Teaching Hospital, University of Jos, Jos, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salaam","family":"Abdul","sequence":"additional","affiliation":[{"name":"Department of Radiology, Jos University Teaching Hospital, University of Jos, Jos, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucius","family":"Imoh","sequence":"additional","affiliation":[{"name":"Department of Chemical Pathology, Jos University Teaching Hospital, University of Jos, Jos, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Ibinaiye","sequence":"additional","affiliation":[{"name":"Department of Radiology, Ahmadu Bello University Teaching Hospital, Ahmadu Bello University, Zaria, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,2,4]]},"reference":[{"key":"CIT0001-20250217","first-page":"521","article-title":"The morphology of cirrhosis: Definition, nomenclature and classification","volume":"55","author":"Anthony","year":"1977","journal-title":"Bull World Health Organ"},{"key":"CIT0003-20250217","doi-asserted-by":"crossref","first-page":"18131","DOI":"10.3748\/wjg.v20.i48.18131","article-title":"Non invasive tools for the diagnosis of Liver cirrhosis","volume":"20","author":"Maurizio","year":"2014","journal-title":"World J Gastroenterol"},{"key":"CIT0004-20250217","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1476-5926-4-6","article-title":"Accuracy of hyaluronic acid level for predicting liver fibrosis stages in patients with hepatitis C virus","volume":"4","author":"Philippe","year":"2005","journal-title":"Comp Hepatol"},{"key":"CIT0005-20250217","doi-asserted-by":"crossref","first-page":"22","DOI":"10.2214\/AJR.15.14552","article-title":"Ultrasound Elastography and MR elastography for assessing liver fibrosis: Part 1, principles and techniques","volume":"205","author":"Tang","year":"2015","journal-title":"AJR Am J Roentgenol"},{"key":"CIT0006-20250217","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1136\/gut.2005.069153","article-title":"Diagnosis of cirrhosis by transient elastography (FibroScan): A prospective study","volume":"55","author":"Foucher","year":"2006","journal-title":"Gut"},{"key":"CIT0007-20250217","doi-asserted-by":"crossref","first-page":"15","DOI":"10.4314\/jmt.v13i1.69326","article-title":"Hepatic histological findings in apparently healthy persons sero-positive for Hepatitis B virus","volume":"13","author":"Okeke","year":"2011","journal-title":"J Med Tropics"},{"key":"CIT0008-20250217","doi-asserted-by":"crossref","first-page":"255","DOI":"10.2174\/157340511798038684","article-title":"An overview of elastography \u2013 an emerging branch of medical imaging","volume":"7","author":"Armen","year":"2011","journal-title":"Curr Med Imaging Rev"},{"key":"CIT0009-20250217","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.arcmed.2006.08.005","article-title":"Liver biopsy assessment in chronic hepatitis","volume":"38","author":"Lefkowitch","year":"2007","journal-title":"Arch Med Res"},{"key":"CIT0010-20250217","article-title":"Evaluation and Staging of Liver Fibrosis.CME\/CNE Self-Study Module","author":"Cox-North","year":"2018"},{"key":"CIT0011-20250217","doi-asserted-by":"crossref","first-page":"107","DOI":"10.4314\/wajm.v24i2.28177","article-title":"Chronic hepatitis in Nigerian patients: A study of 70 biopsy proven cases","volume":"24","author":"Ndububa","year":"2005","journal-title":"West African J Med"},{"key":"CIT0012-20250217","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1186\/1471-2334-10-244","article-title":"Can Serum Hyaluran replace simple non-invasive indexes to predict liver fibrosis in HIV\/Hepatits co-infected persons?","volume":"10","author":"Resino","year":"2010","journal-title":"BMC Infect Dis"},{"key":"CIT0013-20250217","doi-asserted-by":"crossref","first-page":"13920","DOI":"10.3748\/wjg.v20.i38.13920","article-title":"Real time shear wave elastography in chronic liver diseases: Accuracy for predicting liver fibrosis, in comparison with serum markers","volume":"20","author":"Jae","year":"2014","journal-title":"World J Gastroenterol"}],"container-title":["Journal of West African College of Surgeons"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jwas.jwas_82_23","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:43:01Z","timestamp":1787067781000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jwas.jwas_82_23"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,4]]},"references-count":12,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.4103\/jwas.jwas_82_23","relation":{},"ISSN":["2276-6944","2992-5827"],"issn-type":[{"value":"2276-6944","type":"print"},{"value":"2992-5827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,4]]},"assertion":[{"value":"2023-03-31","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-10-26","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}